DSM Entering U.S. Via Catalytica: European Bulk Firms Going Global
DSM plans to establish a U.S. presence for its bulk active ingredient and contract manufacturing operations through the acquisition of Catalytica Pharmaceuticals.
DSM plans to establish a U.S. presence for its bulk active ingredient and contract manufacturing operations through the acquisition of Catalytica Pharmaceuticals.